BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31378855)

  • 1. Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability.
    Diehl P; Nienaber F; Zaldivia MTK; Stamm J; Siegel PM; Mellett NA; Wessinger M; Wang X; McFadyen JD; Bassler N; Puetz G; Htun NM; Braig D; Habersberger J; Helbing T; Eisenhardt SU; Fuller M; Bode C; Meikle PJ; Chen YC; Peter K
    Thromb Haemost; 2019 Aug; 119(8):1295-1310. PubMed ID: 31378855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-derived mesenchymal stem cells microvesicles stabilize atherosclerotic plaques by inhibiting NLRP3-mediated macrophage pyroptosis.
    Lin Y; Liu M; Chen E; Jiang W; Shi W; Wang Z
    Cell Biol Int; 2021 Apr; 45(4):820-830. PubMed ID: 33325118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine.
    Domeij H; Hua X; Su J; Bäcklund A; Yan Z; Frostegård AG; Haeggström JZ; Modéer T; Frostegård J
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():72-8. PubMed ID: 23391726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis.
    Barrett TJ; Schlegel M; Zhou F; Gorenchtein M; Bolstorff J; Moore KJ; Fisher EA; Berger JS
    Sci Transl Med; 2019 Nov; 11(517):. PubMed ID: 31694925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivity.
    Oggero S; de Gaetano M; Marcone S; Fitzsimons S; Pinto AL; Ikramova D; Barry M; Burke D; Montero-Melendez T; Cooper D; Burgoyne T; Belton O; Norling LV; Brennan EP; Godson C; Perretti M
    J Extracell Vesicles; 2021 Apr; 10(6):12084. PubMed ID: 33936566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor.
    Pan Y; Liang H; Liu H; Li D; Chen X; Li L; Zhang CY; Zen K
    J Immunol; 2014 Jan; 192(1):437-46. PubMed ID: 24307738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internalization of Tissue Factor-Rich Microvesicles by Platelets Occurs Independently of GPIIb-IIIa, and Involves CD36 Receptor, Serotonin Transporter and Cytoskeletal Assembly.
    Lopez-Vilchez I; Diaz-Ricart M; Galan AM; Roque M; Caballo C; Molina P; White JG; Escolar G
    J Cell Biochem; 2016 Feb; 117(2):448-57. PubMed ID: 26221761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLEC-2-dependent platelet subendothelial accumulation by flow disturbance contributes to atherogenesis in mice.
    Tang C; Wang L; Sheng Y; Zheng Z; Xie Z; Wu F; You T; Ren L; Xia L; Ruan C; Zhu L
    Theranostics; 2021; 11(20):9791-9804. PubMed ID: 34815786
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients.
    Suades R; Padró T; Alonso R; López-Miranda J; Mata P; Badimon L
    Thromb Haemost; 2014 Jan; 111(1):111-21. PubMed ID: 24085382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
    Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
    Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
    FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Contribution of Monocyte- and Platelet-Derived Microvesicles to Endothelial Behavior.
    Brambilla M; Talmon M; Canzano P; Fresu LG; Brunelleschi S; Tremoli E; Camera M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL4-induced macrophages in human atherosclerosis.
    Domschke G; Gleissner CA
    Cytokine; 2019 Oct; 122():154141. PubMed ID: 28899579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
    Ménégaut L; Masson D; Abello N; Denimal D; Truntzer C; Ducoroy P; Lagrost L; Pais de Barros JP; Athias A; Petit JM; Martin L; Steinmetz E; Kretz B
    Atherosclerosis; 2016 Aug; 251():339-347. PubMed ID: 27189320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
    Suades R; Padró T; Alonso R; Mata P; Badimon L
    Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E inhibits lysophosphatidylcholine-induced endothelial dysfunction and platelet activation.
    Murohara T; Ikeda H; Katoh A; Takajo Y; Otsuka Y; Haramaki N; Imaizumi T
    Antioxid Redox Signal; 2002 Oct; 4(5):791-8. PubMed ID: 12470507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13.
    Halvorsen B; Smedbakken LM; Michelsen AE; Skjelland M; Bjerkeli V; Sagen EL; Taskén K; Bendz B; Gullestad L; Holm S; Biessen EA; Aukrust P
    Atherosclerosis; 2014 Jun; 234(2):352-9. PubMed ID: 24732574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
    Huo Y; Schober A; Forlow SB; Smith DF; Hyman MC; Jung S; Littman DR; Weber C; Ley K
    Nat Med; 2003 Jan; 9(1):61-7. PubMed ID: 12483207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins.
    Korotaeva AA; Cheglakov IB; Morozkin AD; Suslova IV; Prokazova NV
    Membr Cell Biol; 1997; 10(5):521-34. PubMed ID: 9225256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets.
    Kokjohn TA; Van Vickle GD; Maarouf CL; Kalback WM; Hunter JM; Daugs ID; Luehrs DC; Lopez J; Brune D; Sue LI; Beach TG; Castaño EM; Roher AE
    Biochim Biophys Acta; 2011 Nov; 1812(11):1508-14. PubMed ID: 21784149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.